US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 2.8900
  • +0.0600+2.12%
Close Feb 26 16:00 ET
3.49MMarket Cap-0.23P/E (TTM)

InMed Pharmaceuticals Key Stats

InMed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q31.601M / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
Sep 23, 20222022/Q4698.290K / 969.890K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q31.601M / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
Sep 23, 20222022/Q4698.290K / 969.890K--

Unlock Free Earnings Estimates

InMed Pharmaceuticals Earnings Reports

Read more

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More